BioCardia
BCDA
BCDA
23 hedge funds and large institutions have $5.78M invested in BioCardia in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
22% less call options, than puts
Call options by funds: $149K | Put options by funds: $191K
36% less capital invested
Capital invested by funds: $9.01M → $5.78M (-$3.23M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
23
Holding in Top 10
–
Calls
$149K
Puts
$191K
Top Buyers
| 1 | +$138K | |
| 2 | +$79.9K | |
| 3 | +$63.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$53.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$51.8K |
Top Sellers
| 1 | -$137K | |
| 2 | -$31K | |
| 3 | -$11.7K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
-$11K |
| 5 |
Morgan Stanley
New York
|
-$954 |